wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q43039947-89765FFA-677A-4266-A2F0-45A36FA2BE66
Q43039947-89765FFA-677A-4266-A2F0-45A36FA2BE66
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43039947-89765FFA-677A-4266-A2F0-45A36FA2BE66
First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline.
P2860
Q43039947-89765FFA-677A-4266-A2F0-45A36FA2BE66
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43039947-89765FFA-677A-4266-A2F0-45A36FA2BE66
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3025d44f3d5b2ebab64d898b0511a79b032bca7c
P2860
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I